Green Cross Holdings Corporation (005250.KS)

KRW 13460.0

(1.58%)

Inventory Summary of Green Cross Holdings Corporation

  • Green Cross Holdings Corporation's latest annual inventory in 2023 was 579.72 Billion KRW , up 14.78% from previous year.
  • Green Cross Holdings Corporation's latest quarterly inventory in 2024 Q2 was 693.41 Billion KRW , up 4.52% from previous quarter.
  • Green Cross Holdings Corporation reported annual inventory of 505.08 Billion KRW in 2022, down -0.38% from previous year.
  • Green Cross Holdings Corporation reported annual inventory of 506.99 Billion KRW in 2021, up 3.65% from previous year.
  • Green Cross Holdings Corporation reported quarterly inventory of 663.42 Billion KRW for 2024 Q1, up 14.44% from previous quarter.
  • Green Cross Holdings Corporation reported quarterly inventory of 571.32 Billion KRW for 2023 Q2, up 4.03% from previous quarter.

Annual Inventory Chart of Green Cross Holdings Corporation (2023 - 2007)

Historical Annual Inventory of Green Cross Holdings Corporation (2023 - 2007)

Year Inventory Inventory Growth
2023 579.72 Billion KRW 14.78%
2022 505.08 Billion KRW -0.38%
2021 506.99 Billion KRW 3.65%
2020 489.14 Billion KRW 7.79%
2019 453.77 Billion KRW 5.16%
2018 431.5 Billion KRW -13.09%
2017 496.47 Billion KRW 1.78%
2016 487.81 Billion KRW -6.84%
2015 523.63 Billion KRW 22.3%
2014 428.14 Billion KRW 53.34%
2013 279.21 Billion KRW 25.41%
2012 222.64 Billion KRW 6.24%
2011 209.57 Billion KRW 3.73%
2010 202.03 Billion KRW -10.16%
2009 224.89 Billion KRW 75.56%
2008 128.09 Billion KRW 37.24%
2007 93.34 Billion KRW 0.0%

Peer Inventory Comparison of Green Cross Holdings Corporation

Name Inventory Inventory Difference
ORIENT BIO Inc. 3.65 Billion KRW -15763.805%
Green Cross Holdings Corporation 516.24 Billion KRW -12.297%
Pharmicell Co., Ltd. 20.87 Billion KRW -2677.491%
Green Cross Corporation 516.24 Billion KRW -12.297%
GeneOne Life Science, Inc. 14.89 Billion KRW -3791.593%
Celltrion, Inc. 3041.45 Billion KRW 80.939%
Samsung Biologics Co.,Ltd. 2641.36 Billion KRW 78.052%
SK bioscience Co.,Ltd. 80.64 Billion KRW -618.826%
SK Biopharmaceuticals Co., Ltd. 102.52 Billion KRW -465.448%
Prestige BioPharma Limited 18.1 Billion KRW -3102.389%